Stockscreener 앱 받기
0.155
86.97%
-1.035
전일 마감가:
$1.19
열려 있는:
$0.155
하루 거래량:
505
Relative Volume:
6.23
시가총액:
$N/A
수익:
$662.00K
순이익/손실:
$-29.02M
주가수익비율:
-0.0182
EPS:
-8.5
순현금흐름:
$-12.54M
1주 성능:
-86.97%
1개월 성능:
-86.97%
6개월 성능:
-86.97%
1년 성능:
-86.10%
1일 변동 폭
$0.155
$0.155
1주일 범위
$0.155
$0.155
52주 변동 폭
$0.155
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
ORGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.155 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-12-20 | 개시 | Dawson James | Buy |
Orgenesis Inc 주식(ORGS)의 최신 뉴스
Is Orgenesis Inc. (45O) stock a safe buy pre earnings2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда
Retail Trends: Is Orgenesis Inc 45O stock a safe buy pre earnings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - moha.gov.vn
Aug Gainers: Is Orgenesis Inc 45O stock a safe buy pre earningsInflation Watch & Verified Swing Trading Watchlists - Bộ Nội Vụ
Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant
Published on: 2025-12-23 22:10:30 - earlytimes.in
Regenerative Therapies Market Forecast Through 2032 - openPR.com
Statera Biopharma (NASDAQ:STAB) vs. Orgenesis (NASDAQ:ORGS) Financial Contrast - Defense World
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer - Business Wire
Is Oriental Culture Holding LTD a good long term investmentUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
Financial Contrast: Pharmaxis (OTCMKTS:PXSLY) and Orgenesis (NASDAQ:ORGS) - Defense World
What analysts say about GoPro Inc stockResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
How Orgenesis Inc. (45O) stock trades in high volatility2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Is Orgenesis Inc. (45O) stock suitable for passive index fundsWeekly Gains Report & Precise Swing Trade Alerts - Newser
Apex Tech Acquisition Inc files for IPO of up to $60 million - marketscreener.com
Is Orgenesis Inc. (45O) stock protected from inflation2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
How Orgenesis Inc. (45O) stock compares with top peersShort Setup & Accurate Entry/Exit Alerts - Newser
Why Orgenesis Inc. (45O) stock attracts HNW investorsJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
Will Orgenesis Inc. (45O) stock beat international competition2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Orgenesis (NASDAQ:ORGS) Stock Price Up 257.1% – Here’s Why - Defense World
Will Orgenesis Inc. (45O) stock gain from lower interest ratesProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Orgenesis Inc. (45O) stock a buy during volatile marketsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Why Orgenesis Inc. (45O) stock is a strong analyst pick2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsMarket Growth Report & Community Verified Trade Alerts - newser.com
Orgenesis Inc (ORGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):